lansoprazole has been researched along with Behcet Syndrome in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Behcet Syndrome: Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.
Excerpt | Relevance | Reference |
---|---|---|
"Lansoprazole (30 mg) was given as a probe drug to evaluate CYP2C19 activity in 59 patients with BD and 27 healthy control volunteers." | 1.46 | Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behçet's Disease. ( Akdogan, A; Babaoglu, MO; Bertilsson, L; Bozkurt, A; Cevik, L; Goktas, MT; Kalkisim, S; Karaca, RO; Kilic, L; Yasar, U, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goktas, MT | 1 |
Karaca, RO | 1 |
Kalkisim, S | 1 |
Cevik, L | 1 |
Kilic, L | 1 |
Akdogan, A | 1 |
Babaoglu, MO | 1 |
Bozkurt, A | 1 |
Bertilsson, L | 1 |
Yasar, U | 1 |
Kobayashi, S | 1 |
Kawabe, N | 1 |
Miyata, F | 1 |
Ito, H | 1 |
Kazumiya, H | 1 |
Murase, K | 1 |
Kurokawa, S | 1 |
Fujishima, K | 1 |
2 other studies available for lansoprazole and Behcet Syndrome
Article | Year |
---|---|
Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behçet's Disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents; Behcet Syndrome; Biotransformatio | 2017 |
[A case of Behcet's syndrome associated with esophageal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Inflammatory Agents; Anti-Ulcer Agents; Behcet | 1998 |